IP Library Granted Patent US 12,377,055
Granted Patent B2
US 12,377,055 · App. 18/667,290 · Granted Aug 5, 2025

Dissolvable gel-forming film for delivery of active agents

Inventors: Lei Shi (Mansfield, TX); Aleksa Jovanovic (Fort Worth, TX); Dennis Carson (Burleson, TX)
Assignee: SMITH & NEPHEW, INC.
A61K9/7007A61K38/4873A61K38/4886A61K47/10A61K47/38A61L15/28A61L15/38A61L15/44A61L15/60A61L15/62C12Y304/22002C12Y304/24027
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,377,055
App. No.
18/667,290
Granted
Aug 5, 2025
Kind
B2
Abstract

Disclosed is a dissolvable, gel-forming film, and methods for its use, comprising a water-soluble cellulose ether, a hydrophilic rheological modifying agent, and an active proteolytic enzyme or other drug substance. The gel-forming film has a water content of less than 15% w/w and is capable of forming a hydrogel when contacted with water or other aqueous medium. The disclosed films achieve delivery of stable proteolytic enzymes to the desired site of action in a manner that provides uniform delivery of the enzymes.

Claims (28)

1. A method of applying a dissolvable, gel-forming film to a surface,

wherein the dissolvable, gel-forming film comprises a water-soluble cellulose ether, a hydrophilic rheological modifying agent, and a protease,

wherein the dissolvable, gel-forming film has a water content of less than 15% w/w, and

wherein the dissolvable, gel-forming film is capable of forming a hydrogel when 1 gm of gel-forming film is contacted with 20 ml of water or other aqueous medium.

2. The method of claim 1 , wherein the water-soluble cellulose ether is a hydroxyalkyl cellulose ether.

3. The method of claim 2 , wherein the hydroxyalkyl cellulose ether is hydroxyethylcellulose, hydroxypropylcellulose, or hydroxypropylmethylcellulose, or any combination thereof.

4. The method of claim 1 , wherein the dissolvable, gel-forming film comprises 50 to 70% w/w or 55 to 65% w/w of the water-soluble cellulose ether.

5. The method of claim 1 , wherein the hydrophilic rheological modifying agent is a polyol.

6. The method of claim 5 , wherein the polyol is polyethylene glycol.

7. The method of claim 1 , wherein the dissolvable, gel-forming film comprises 15 to 25% w/w of the hydrophilic rheological modifying agent.

8. The method of claim 1 , wherein the hydrogel comprises 5 to 15% w/w of the protease.

9. The method of claim 1 , wherein the protease is thermolysin.

10. The method of claim 1 , wherein the dissolvable, gel-forming film further comprises a preservative, a metal salt, a buffer, or a combination thereof.

11. The method of claim 10 , wherein:

the preservative is methylparaben, propylparaben, or phenoxyethanol, or mixtures thereof;

the metal salt is sodium chloride or calcium chloride or mixtures thereof; or

the buffer has a pH of about 7.5.

12. The method of claim 1 , wherein the dissolvable, gel-forming film has a thickness of 10 to 1000 μM.

13. The method of claim 1 , wherein the surface is a wound.

14. The method of claim 13 , wherein an aqueous medium is applied to the wound:

before the dissolvable, gel-forming film is applied to the wound; or

after the dissolvable, gel-forming film is applied to the wound.

15. The method of claim 14 , wherein the aqueous medium is a saline solution.

16. The method of claim 13 , wherein a bandage, wound dressing, or gauze is applied onto the dissolvable, gel-forming film after the film is applied to the wound.

17. The method of claim 13 , wherein the wound is in need of debridement, and wherein application of the dissolvable, gel-forming film debrides the wound.

18. The method of claim 13 , wherein the wound is a chronic wound.

19. The method of claim 18 , wherein the chronic wound is a diabetic foot ulcer, a venous leg ulcer, an arterial leg ulcer, a decubitus ulcer, a stasis ulcer, a dermal ulcer, a burn, or a pressure ulcer.

20. The method of claim 13 , wherein the wound includes necrotic or devitalized tissue.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2024
From: SHI, LEI; CARSON, DENNIS; JOVANOVIC, ALEKSA
To: SMITH & NEPHEW, INC.
Reel/Frame 067459/0457 →
Continuity (4)
Continuation 17892435 · Aug 22, 2022
Continuation 14769754
Provisional Application 61790132 · Mar 15, 2013
Related Publication 20240382433A1 · Nov 21, 2024
References Cited (85)
US 3983209A · Schmitt · 1976 [cited by applicant]
US 4136162A · Fuchs et al. · 1979 [cited by applicant]
US 4228277A · Landoll · 1980 [cited by applicant]
US 4292299A · Suzuki et al. · 1981 [cited by applicant]
US 4517173A · Kizawa et al. · 1985 [cited by applicant]
US 4784653A · Bolton et al. · 1988 [cited by applicant]
US RE33093E · Schiraldi et al. · 1989 [cited by applicant]
US 5145681A · Fortney et al. · 1992 [cited by applicant]
US 5206026A · Sharik et al. · 1993 [cited by applicant]
US 5393528A · Staab · 1995 [cited by applicant]
US 5700478A · Biegajski et al. · 1997 [cited by applicant]
US 5739023A · Harada et al. · 1998 [cited by applicant]
US 6159498A · Tapolsky et al. · 2000 [cited by applicant]
US 6177096B1 · Zerbe et al. · 2001 [cited by applicant]
US 6228416B1 · Reibert et al. · 2001 [cited by applicant]
US 6235893B1 · Reibert · 2001 [cited by examiner]
US 6399091B1 · Berthold et al. · 2002 [cited by applicant]
US 6458380B1 · Leadennan · 2002 [cited by applicant]
US 6518054B1 · Van den Burg et al. · 2003 [cited by applicant]
US 6548556B2 · Hobson et al. · 2003 [cited by applicant]
US 6635272B2 · Leaderman · 2003 [cited by applicant]
US 6906043B2 · Awamura et al. · 2005 [cited by applicant]
US 7067116B1 · Bess et al. · 2006 [cited by applicant]
US 7132113B2 · Zerbe et al. · 2006 [cited by applicant]
US 7357891B2 · Yang et al. · 2008 [cited by applicant]
US 7368128B2 · Qvist · 2008 [cited by applicant]
US 7425292B2 · Yang et al. · 2008 [cited by applicant]
US 7666337B2 · Yang et al. · 2010 [cited by applicant]
US 7785584B2 · Jones et al. · 2010 [cited by applicant]
US 7824588B2 · Yang et al. · 2010 [cited by applicant]
US 8163298B2 · Griffiths-Brophy et al. · 2012 [cited by applicant]
US 9045743B2 · Hoelke et al. · 2015 [cited by applicant]
US 10058596B2 · Hanson · 2018 [cited by applicant]
US 20030008830A1 · Prozillo · 2003 [cited by applicant]
US 20030027833A1 · Cleary et al. · 2003 [cited by applicant]
US 20030107149A1 · Yang et al. · 2003 [cited by applicant]
US 20030175333A1 · Shefer et al. · 2003 [cited by applicant]
US 20030198631A1 · Shi et al. · 2003 [cited by applicant]
US 20030198632A1 · Shi · 2003 [cited by examiner]
US 20040028739A1 · Rippon et al. · 2004 [cited by applicant]
US 20040151765A1 · Ritchie et al. · 2004 [cited by applicant]
US 20050118217A1 · Barnhart et al. · 2005 [cited by applicant]
US 20050186257A1 · Manegold et al. · 2005 [cited by applicant]
US 20050196358A1 · Georgiades et al. · 2005 [cited by applicant]
US 20050208108A1 · Jannusch et al. · 2005 [cited by applicant]
US 20060172000A1 · Cullen et al. · 2006 [cited by applicant]
US 20070154527A1 · Myers et al. · 2007 [cited by applicant]
US 20080085291A1 · Lombardo · 2008 [cited by applicant]
US 20080124381A1 · Barnhart · 2008 [cited by examiner]
US 20080152698A1 · Effing et al. · 2008 [cited by applicant]
US 20080220029A1 · Ng et al. · 2008 [cited by applicant]
US 20080254105A1 · Tapolsky et al. · 2008 [cited by applicant]
US 20080279842A1 · Qvist · 2008 [cited by applicant]
US 20090010910A1 · Toren et al. · 2009 [cited by applicant]
US 20090263468A1 · McAnulty et al. · 2009 [cited by applicant]
US 20100021416A1 · Lichter et al. · 2010 [cited by applicant]
US 20100159564A1 · Dwulet et al. · 2010 [cited by applicant]
US 20110190722A1 · Munro et al. · 2011 [cited by applicant]
US 20130045196A1 · Shi et al. · 2013 [cited by applicant]
US 20140154235A1 · Shi et al. · 2014 [cited by applicant]
US 20150283217A1 · Shi et al. · 2015 [cited by applicant]
CN 1929826 · 2007 [cited by applicant]
CN 102573760 · 2012 [cited by applicant]
GB 2147206 · 1985 [cited by applicant]
JP 2006503044 · 2006 [cited by applicant]
JP 2007500673 · 2007 [cited by applicant]
JP 200752673 · 2007 [cited by applicant]
JP 2011507920 · 2011 [cited by applicant]
RU 2276998 · 2006 [cited by applicant]
WO WO1999044631 · 1999 [cited by applicant]
WO WO2004009050 · 2004 [cited by applicant]
WO WO2005035010 · 2005 [cited by applicant]
WO WO2006037606 · 2006 [cited by applicant]
WO WO2007128985 · 2007 [cited by applicant]
WO WO2010038231 · 2010 [cited by applicant]
WO WO2011071986 · 2011 [cited by applicant]
WO WO2012155027 · 2012 [cited by applicant]
WO WO2013170128 · 2013 [cited by applicant]
Ashland Physical Chemical Property Book, “Klucel™ hydroxypropylcellulose Physical and Chemical Properties,” 2017. [cited by applicant]
Ashland Product Data “Natrosol™ 250 Water Soluble Hydroxyethylcellulose, ”Ashland Specialty Ingredients, 2015. [cited by applicant]
Jen, A. et al.: “Diamonds in the Rough: Protein Crystals from a Formulation Perspective”, Pharmaceutical Research, vol. 18, No. 11, (Nov. 200 I), pp. 1483-1488. [cited by applicant]
Lin et al., Hydrogels in controlled release formulations: Network design and mathematical modeling, Advanced Drug Delivery Reviews 58 (2006) 1379-1408. [cited by applicant]
Milne, C.T., et al., “A comparison of collagenase to hydrogel dressings in wound debridement”, [cited by applicant]
Shenoy, B. et al.: “Stability of Crystalline Proteins”, Biotechnology and Bioengineering, vol. 73, No. 5, (Jun. 2001), pp. 358-369. [cited by applicant]
Office Action issued in U.S. Appl. No. 18/667,369, dated Mar. 26, 2025. [cited by applicant]